ARCEDI Biotech ApS is a Danish biotech company involved in developing technologies for rare cell detection, a widely sought after application in the prenatal as well as cancer diagnostics.

ARCEDI Biotech has proprietary method to enrich fetal cells from circulating maternal blood with high efficiency. Once enriched, the fetal cells are analyzed by whole genome sequencing. 

ARCEDI launched EVITA TEST COMPLETE, world's first and only cell-based NIPT which is currently being offered via 23 clinics in Denmark.

ARCEDI Biotech

Org chart

Teams

Offices